Sean Connor, General Manager Benelux and UK/ROI for ALK, details the company’s strategy both in terms of products and therapeutic areas and provides…

Wiebke Rieb describes Pfizer’s commitment to ensuring patient access to the necessary treatments and working with all stakeholders to further…

A well-established player in the Allergy market, the Dutch company HAL Allergy recently expanded its activities with the addition of its HALIX…

With almost thirty years of experience in the life sciences sector, local Dutch consultancy firm Baggerman Farma Consult offers a wide portfolio of…

John Verhoeven, Partner and co-founder of Eagle Rock Life Sciences, a Dutch independent consultancy offering a broad range of services to both Dutch…

Manfred Rüdiger (MR), Robbert Van Heekeren (RVH) and Jeroen Rovers (JR), respectively CEO, CFO and CMO of Kiadis Pharma, a Dutch biopharmaceutical…

Antimicrobial resistance is classified by the WHO as one of the top threats to humanity. The Business Unit Director for Europe and America of DSM…

Rikus Wolbers, Director at Novio Tech Campus, a key international incubator for R&D and manufacturing companies who are active at the interface of…

After a successful IPO on Nasdaq in May 2015, Galapagos is ready to continue developing its robust portfolio of clinical-stage breakthrough therapies…

Leo Le Duc, Director of Amsterdam Science Park, explains the potential of Amsterdam Science Park as a world-class eco-system for start-ups, mature…

The CSO and COO of BioNovion talk about the company's recent acquisition by US-based biotech Aduro. BioNovion is a Dutch biopharma specialized in…

Stem cell technology can play a key role in improving the drug discovery process. The CEO of Pluriomics, a biotech company focused on development of…